- Home
- ASND vs CRL Comparison
ASND vs CRL Comparison
Compare ASND & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | CRL |
|---|---|---|
| Founded | 2006 | 1947 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 13.1B |
| IPO Year | 2014 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ASND | CRL |
|---|---|---|
| Price | $243.54 | $344.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 18 |
| Target Price | $306.03 | ★ $315.53 |
| AVG Volume (30 Days) | 683.6K | ★ 1.0M |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $90.81 | N/A |
| Revenue Next Year | $46.89 | $2.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $188.07 | $146.20 |
| 52 Week High | $282.15 | $351.21 |
Technical Indicators
Market Signals| Indicator | ASND | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 72.88 |
| Support Level | $242.17 | $151.03 |
| Resistance Level | $249.89 | N/A |
| Average True Range (ATR) | 6.21 | 14.50 |
| MACD | 2.90 | 4.19 |
| Stochastic Oscillator | 97.35 | 89.89 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.